Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126277262 | 12627726 | 2 | F | 20160802 | 20160805 | 20160907 | EXP | US-ASTRAZENECA-2016SE53097 | ASTRAZENECA | 0.00 | F | Y | 0.00000 | 20160907 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126277262 | 12627726 | 1 | PS | IRESSA | GEFITINIB | 1 | Oral | U | 206995 | 250 | MG | TABLET | QD | ||||||
| 126277262 | 12627726 | 2 | C | WARFARIN | WARFARIN | 1 | 0 | 3 | MG | QD | |||||||||
| 126277262 | 12627726 | 3 | C | PAIN MEDICATION | UNSPECIFIED INGREDIENT | 1 | 0 | ||||||||||||
| 126277262 | 12627726 | 4 | C | GILOTRIF | AFATINIB | 1 | 0 | ||||||||||||
| 126277262 | 12627726 | 5 | C | DIPHENOXYLATE-ATROPINE | 2 | 0 | |||||||||||||
| 126277262 | 12627726 | 6 | C | BENAZEPRIL | BENAZEPRIL HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 126277262 | 12627726 | 7 | C | HCTZ | HYDROCHLOROTHIAZIDE | 1 | 0 | ||||||||||||
| 126277262 | 12627726 | 8 | C | NAPROXEN. | NAPROXEN | 1 | 0 | ||||||||||||
| 126277262 | 12627726 | 9 | C | CALCIUM | CALCIUM | 1 | 0 | ||||||||||||
| 126277262 | 12627726 | 10 | C | ZOMETA | ZOLEDRONIC ACID | 1 | 0 | ||||||||||||
| 126277262 | 12627726 | 11 | C | FENTANYL. | FENTANYL | 1 | 0 | ||||||||||||
| 126277262 | 12627726 | 12 | C | METRONIDAZOLE. | METRONIDAZOLE | 1 | 0 | ||||||||||||
| 126277262 | 12627726 | 13 | C | CIPROFLOXACIN. | CIPROFLOXACIN | 1 | 0 | ||||||||||||
| 126277262 | 12627726 | 14 | C | HYRDOCODONE | 2 | 0 | |||||||||||||
| 126277262 | 12627726 | 15 | C | MEGESTROL | MEGESTROL | 1 | 0 | ||||||||||||
| 126277262 | 12627726 | 16 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126277262 | 12627726 | 1 | Lung carcinoma cell type unspecified stage 0 |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126277262 | 12627726 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126277262 | 12627726 | Arthralgia | |
| 126277262 | 12627726 | Deep vein thrombosis | |
| 126277262 | 12627726 | Dry skin | |
| 126277262 | 12627726 | Dysphagia | |
| 126277262 | 12627726 | Gingival pain | |
| 126277262 | 12627726 | Lip blister | |
| 126277262 | 12627726 | Malaise | |
| 126277262 | 12627726 | Mouth swelling | |
| 126277262 | 12627726 | Pharyngitis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126277262 | 12627726 | 1 | 20160509 | 0 |